Critical appraisal of the role of recombinant activated factor VII in the treatment of hemophilia patients with inhibitors
{{output}}
Hemophilia patients with inhibitors faced the constraint of inadequate treatment for several years before the era of recombinant factor VIIa (rFVII). Initially, rFVIIa was used in the compassionate-use programs. After a worldwide license was issued, more than ... ...
